On evolutionary origin of cancer.
BACKGROUND: The necessary and sufficient capabilities of cancer cell have been identified. Strikingly, this list does not include one that would seem to be a key property, namely the ability of cancer cells to kill their "host". This is believed to be a self-evident consequence of the other capabilities (e.g., metastasis), although the available evidence suggests a distinct killer function. Taking into account this unlisted property can significantly affect the current paradigm of carcinogenesis. PRESENTATION OF THE HYPOTHESIS: On the assumption that killer function is a key capability of the cancer cell, it is suggested that cancer has evolved as a mechanism of negative selection of mutant alleles of vitally important genes present in population. Similarly to apoptosis, which is an altruistic suicidal act of a damaged cell, cancer is an altruistic suicidal act of an individual who carries dangerous alleles and presents a hazard for genetic stability of the population. From this point of view, apoptosis is not a protection means against cancer as generally believed, but rather they are the first and second lines of defense against genome instability, respectively. TESTING THE HYPOTHESIS: The modern DNA array technology is capable of revealing gene expression profiles responsible for killer function of cancer cell as well as those specific targets in the body that are most strongly affected by the tumor growth. IMPLICATIONS OF THE HYPOTHESIS: This hypothesis suggests new avenues of cancer research as well as principally new therapeutic strategies.
Lichtenstein
Anatoly V
AV
Laboratory of Tumor Biochemistry, Cancer Research Center, Kashirskoye shosse 24, 115478 Moscow, Russia. alicht@online.ru.
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
5279523
Cancer Res. 2001 Apr 15;61(8):3230-9
11309271
Cancer Res. 2003 Apr 15;63(8):1727-30
12702551
Cytokine Growth Factor Rev. 2001 Mar;12(1):1-8
11312113
Nat Rev Cancer. 2003 Apr;3(4):286-95
12671667
Nat Med. 2003 Oct;9(10):1269-74
14502282
Clin Tech Small Anim Pract. 2003 May;18(2):123-6
12831075
J Theor Biol. 1964 Jul;7(1):1-16
5875341
Genes Dev. 2001 Jan 1;15(1):50-65
11156605
Science. 2003 Aug 1;301(5633):643-6
12893942
Nat Rev Cancer. 2002 May;2(5):331-41
12044009
Nat Rev Cancer. 2002 Jul;2(7):537-43
12094240
Mutat Res. 2000 Jan 17;447(1):117-35
10686308
Ann N Y Acad Sci. 1997 Dec 29;833:58-67
9616740
Cell. 2002 Dec 27;111(7):923-5
12507419
Cell. 2000 Jan 7;100(1):57-70
10647931
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14800-3
8962135
Nat Rev Cancer. 2003 May;3(5):362-74
12724734
Nat Rev Genet. 2004 Oct;5(10):764-72
15510167
Exp Cell Res. 2001 Mar 10;264(1):169-84
11237532
Br J Cancer. 1975 Oct;32(4):411-26
1212409
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14952-7
12397172
Mol Carcinog. 1993;7(3):139-46
8489711
Nature. 2001 May 17;411(6835):336-41
11357140
Nat Rev Cancer. 2004 Jan;4(1):11-22
14708024
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7036-40
1495998
Blood. 1999 Jun 1;93(11):3956-63
10339505
Nat Rev Cancer. 2003 Jun;3(6):434-43
12778133
Proc Biol Sci. 1999 Mar 7;266(1418):493-8
10189713
J Chin Med Assoc. 2003 Sep;66(9):537-43
14649678
Nature. 2001 May 17;411(6835):375-9
11357145
Nature. 2000 Nov 9;408(6809):233-8
11089980
Br J Cancer. 2003 Feb 24;88(4):487-90
12592359
Nat Rev Cancer. 2001 Oct;1(1):46-54
11900251
Nat Rev Cancer. 2003 May;3(5):339-49
12724732
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16226-31
12446840
J Am Geriatr Soc. 1997 Apr;45(4):482-8
9100719
Ann N Y Acad Sci. 2002 Apr;959:214-37
11976198
Nat Rev Cancer. 2003 Jul;3(7):517-25
12835671
Eur J Cancer. 2001 Oct;37 Suppl 8:S88-96
11602375
Nat Rev Cancer. 2004 Jan;4(1):71-8
14708027
Science. 2004 Feb 6;303(5659):848-51
14764882
Nature. 2003 Apr 3;422(6931):494
12673242
Cancer Res. 1991 Jun 15;51(12):3198-203
2039996
Nature. 2004 Nov 4;432(7013):48-52
15525979
Nat Rev Cancer. 2003 Jun;3(6):401-10
12778130
Nat Rev Cancer. 2003 Mar;3(3):226-31
12612657
Nat Rev Genet. 2003 Sep;4(9):721-34
12951573
Adv Cancer Res. 1997;71:209-40
9111867
Nat Rev Cancer. 2003 Jun;3(6):411-21
12778131
Anticancer Res. 1999 Nov-Dec;19(6A):4845-52
10697598
Am J Pathol. 2002 Mar;160(3):755-8
11891172
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10914-21
7902574
Cell Death Differ. 2002 Apr;9(4):367-93
11965491
Nature. 2000 Nov 9;408(6809):248-54
11089982
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8061-5
15141087
Nat Rev Cancer. 2002 Nov;2(11):862-71
12415256
Nat Rev Cancer. 2004 Mar;4(3):177-83
14993899